Opioid use prior to total knee replacement: comparative analysis of trends in England and Sweden.


Journal

Osteoarthritis and cartilage
ISSN: 1522-9653
Titre abrégé: Osteoarthritis Cartilage
Pays: England
ID NLM: 9305697

Informations de publication

Date de publication:
06 2022
Historique:
received: 13 09 2021
revised: 26 01 2022
accepted: 16 02 2022
pubmed: 22 3 2022
medline: 20 5 2022
entrez: 21 3 2022
Statut: ppublish

Résumé

To describe and compare trends in the frequency of opioid prescribing/dispensing in English and Swedish patients with osteoarthritis prior to total knee replacement (TKR). 49,043 patients from an English national database (Clinical Practice Research Datalink) and 5,955 patients from the Swedish Skåne Healthcare register undergoing TKR between 2015 and 2019 were included, alongside 1:1 age-, sex-, and practice (residential area) matched controls. Annual prevalence and prevalence rates ratio (PRR) of opioid prescribing/dispensing (any, by strength) in the 10 years prior to TKR (or matched index date for controls) were estimated using Poisson regression. In England and Sweden, the prevalence of patients with osteoarthritis receiving any opioid prior to TKR increased towards the date of surgery from 24% to 44% in England and from 16% to 33% in Sweden. Prescribing in controls was stable, resulting in an increasing PRR (1.6-2.7) between 10 and 1 years prior to index date in both countries. No relevant cohort or period effect was observed in either country. Prevalence of opioid prescribing was higher in English cases and controls; weaker opioids were more commonly prescribed in England, stronger opioids in Sweden. Temporal prevalence patterns of opioid prescribing between cases and controls are similar in England and Sweden. Opioids are still commonly used in TKR cases in both countries highlighting the lack of valid alternatives for OA pain management.

Identifiants

pubmed: 35307536
pii: S1063-4584(22)00687-2
doi: 10.1016/j.joca.2022.02.621
pii:
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

815-822

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

D Yu (D)

Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Staffordshire, ST5 5BG, United Kingdom.

C Hellberg (C)

Department of Clinical Sciences Lund, Clinical Epidemiology Unit, Orthopaedics, Lund University, Lund, Sweden.

T Appleyard (T)

Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Staffordshire, ST5 5BG, United Kingdom.

A Dell'Isola (A)

Department of Clinical Sciences Lund, Clinical Epidemiology Unit, Orthopaedics, Lund University, Lund, Sweden.

G E R Thomas (GER)

Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Staffordshire, ST5 5BG, United Kingdom.

A Turkiewicz (A)

Department of Clinical Sciences Lund, Clinical Epidemiology Unit, Orthopaedics, Lund University, Lund, Sweden.

M Englund (M)

Department of Clinical Sciences Lund, Clinical Epidemiology Unit, Orthopaedics, Lund University, Lund, Sweden. Electronic address: martin.englund@med.lu.se.

G Peat (G)

Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Staffordshire, ST5 5BG, United Kingdom. Electronic address: g.m.peat@keele.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH